methylprednisolone has been researched along with Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ariizumi, Y; Hiruma, K; Imai, T; Maki, F; Okuma, H; Shinohara, K; Uchino, K; Yamano, Y | 1 |
| Kataria, K; Kumar, A; Kumar, C; Saha, S | 1 |
| Schuele, S; Stevens, GH; Tavee, JO; Widdess-Walsh, P | 1 |
1 review(s) available for methylprednisolone and Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration
| Article | Year |
|---|---|
Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature.
Topics: Anti-Inflammatory Agents; Autoantigens; DNA-Binding Proteins; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Middle Aged; Neoplasm Proteins; Nerve Tissue Proteins; Ovarian Neoplasms; Paraneoplastic Cerebellar Degeneration | 2003 |
2 other study(ies) available for methylprednisolone and Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration
| Article | Year |
|---|---|
Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.
Topics: Antibodies, Neoplasm; Autoantibodies; Female; Fluorodeoxyglucose F18; Humans; Methylprednisolone; Middle Aged; Paraneoplastic Cerebellar Degeneration; Submandibular Gland Neoplasms | 2022 |
Paraneoplastic cerebellar degeneration as a manifestation of metastatic recurrent carcinoma breast: rare scenario.
Topics: Axilla; Breast Neoplasms; Cicatrix; Combined Modality Therapy; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Neuroprotective Agents; Paraneoplastic Cerebellar Degeneration; Pulse Therapy, Drug; Treatment Outcome | 2018 |